Search Results - "Macher, Hada C"

Refine Results
  1. 1

    Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor by Macher, Hada C, Suárez-Artacho, Gonzalo, Guerrero, Juan M, Gómez-Bravo, Miguel A, Álvarez-Gómez, Sara, Bernal-Bellido, Carmen, Dominguez-Pascual, Inmaculada, Rubio, Amalia

    Published in PloS one (09-12-2014)
    “…Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP by Muñoz-Hernandez, Rocio, Vallejo-Vaz, Antonio J, Sanchez Armengol, Angeles, Moreno-Luna, Rafael, Caballero-Eraso, Candela, Macher, Hada C, Villar, Jose, Merino, Ana M, Castell, Javier, Capote, Francisco, Stiefel, Pablo

    Published in PloS one (27-03-2015)
    “…This study tries to assess the endothelial function in vivo using flow-mediated dilatation (FMD) and several biomarkers of endothelium formation/restoration…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Prenatal genetic diagnosis of monogenic diseases by Prior-de Castro, Carmen, Gómez-González, Clara, Rodríguez-López, Raquel, Macher, Hada C

    Published in Advances in laboratory medicine (11-04-2023)
    “…Prenatal genetic diagnosis of monogenic diseases is a process involving the use of a variety of molecular techniques for the molecular characterization of a…”
    Get full text
    Journal Article
  7. 7

    Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum by Macher, Hada C, Martinez-Broca, Maria A, Rubio-Calvo, Amalia, Leon-Garcia, Cristina, Conde-Sanchez, Manuel, Costa, Alzenira, Navarro, Elena, Guerrero, Juan M

    Published in PloS one (07-12-2012)
    “…The multiple endocrine neoplasia type 2A (MEN2A) is a monogenic disorder characterized by an autosomal dominant pattern of inheritance which is characterized…”
    Get full text
    Journal Article
  8. 8

    Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis by Bustamante, Alejandro, Mancha, Fernando, Macher, Hada C, García-Berrocoso, Teresa, Giralt, Dolors, Ribó, Marc, Guerrero, Juan M, Montaner, Joan

    Published in Journal of circulating biomarkers (01-01-2016)
    “…Circulating cell-free DNA (cfDNA) has been described as a prognostic marker for several diseases. Its prognostic value for short-term outcome in stroke…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Noninvasive prenatal diagnosis by cell‐free DNA screening for fetomaternal HPA‐1a platelet incompatibility by Ferro, Marta, Macher, Hada C., Fornés, Gema, Martín‐Sánchez, Jesús, Jimenez‐Arriscado, Pilar, Molinero, Patrocinio, Pérez‐Simón, José A., Guerrero, Juan M., Rubio, Amalia

    Published in Transfusion (Philadelphia, Pa.) (01-10-2018)
    “…BACKGROUND The development of new noninvasive approaches for the diagnosis of human platelet antigen (HPA)‐1 fetomaternal incompatibility has become of great…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Non-invasive Prenatal Diagnosis of Feto-Maternal Platelet Incompatibility by Cold High Resolution Melting Analysis by Ferro, Marta, Macher, Hada C, Noguerol, Pilar, Jimenez-Arriscado, Pilar, Molinero, Patrocinio, Guerrero, Juan M, Rubio, Amalia

    “…Fetal and Neonatal alloimmune thrombocytopenia (FNAIT) is a condition which could occur when pregnant women develop an alloimmunization against paternally…”
    Get more information
    Journal Article
  14. 14

    Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome by Miranda, Maria L., Macher, Hada C., Muñoz-Hernández, Rocio, Vallejo-Vaz, Antonio, Moreno-Luna, Rafael, Villar, Jose, Guerrero, Juan M., Stiefel, Pablo

    Published in American journal of hypertension (01-12-2013)
    “…BACKGROUND Increased plasma levels of circulating cell-free DNA (c-f DNA) have been recently described in diseases related to ischemia and/or hypoxia…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Pleural fluid cell-free DNA in parapneumonic pleural effusion by Santotoribio, Jose D., Cabrera-Alarcón, Jose L., Batalha-Caetano, Paula, Macher, Hada C., Guerrero, Juan M.

    Published in Clinical biochemistry (01-10-2015)
    “…To measure the accuracy of pleural fluid cell-free DNA (cfDNA) concentration for diagnosis of parapneumonic pleural effusions (PPE). We studied pleural fluids…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Screening of KRAS Mutation in Pre- and Post-Surgery Serum of Patients Suffering from Colon Cancer by COLD-PCR HRM by Trujillo-Arribas, Elena, Macher, Hada C, Jiménez-Arriscado, Pilar, de la Portilla, Fernando, Molinero, Patrocinio, Guerrero, Juan M, Rubio, Amalia

    “…Genomic characterization of cell-free circulating tumour DNA (ctDNA) may offer an opportunity to assess clonal dynamics throughout the course of a patient's…”
    Get more information
    Journal Article
  20. 20